Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Psyence Group Inc (PSYGF)

Psyence Group Inc (PSYGF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
FILAMENT HEALTH AND PSYENCE ANNOUNCE WORLDWIDE LICENSING AGREEMENT OF PSILOCYBIN CAPSULE FOR PALLIATIVE CARE Newswire.ca - Thu Dec 15, 2022

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament"), a clinical-stage natural psychedelic drug development company, and Psyence...

FLHLF : 0.0001 (unch)
PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
Psyence Group Corporate Update Globe Newswire - Thu Jun 2, 2022

Highlights: Partnership with CRO Clerkenwell Health to design and deliver Psyence’s UK clinical trial progressing; exclusive licensing agreement with...

PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
Psyence Taps Another Pharma Exec to Drive its Clinical Program Globe Newswire - Tue May 31, 2022

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
Psyence and Filament Health Enter Into Exclusive Licensing Agreement for Natural Psilocybin Products Globe Newswire - Tue Apr 19, 2022

The partnership leverages Psyence’s expertise in fungi cultivation and palliative care as well as Filament’s expertise in the manufacture of pharmaceutical...

PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
FILAMENT HEALTH AND PSYENCE ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR NATURAL PSILOCYBIN PRODUCTS Newswire.ca - Tue Apr 19, 2022

/CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company,...

FLHLF : 0.0001 (unch)
PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)
Psyence looks to expand capital market opportunities in the UK and Europe Globe Newswire - Fri Jan 21, 2022

TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.1200 (unch)
PSYGF : 0.1270 (+11.21%)

Barchart Exclusives

3 Cheapest Dividend Aristocrats for a Lifetime of Income Barchart - Fri Dec 12, 6:00PM CST
Three Dividend Aristocrats near their lows that analysts still say are buys. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot